The forecasted import values for cortisone, hydrocortisone, prednisone, and prednisolone to Canada show a steady incremental trend from 2024 to 2028, with a moderate annual increase. In 2023, the imports were slightly below the initial forecasted value of 7.4513 million USD for 2024, reflecting a stable growth trajectory in the demand for these pharmaceuticals. The year-on-year growth varies negligibly, averaging around 0.24% annually over the five-year period, indicating consistent but modest market expansion in this segment.
Future trends to watch include potential regulatory changes, advancements in alternative therapies, and shifts in healthcare policy, which could influence both the demand and supply chain dynamics of these imported medications in Canada.
